| pubmed-article:16391157 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16391157 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16391157 | lifeskim:mentions | umls-concept:C0242687 | lld:lifeskim |
| pubmed-article:16391157 | lifeskim:mentions | umls-concept:C1522564 | lld:lifeskim |
| pubmed-article:16391157 | lifeskim:mentions | umls-concept:C1277187 | lld:lifeskim |
| pubmed-article:16391157 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
| pubmed-article:16391157 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16391157 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:16391157 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:16391157 | pubmed:dateCreated | 2006-1-18 | lld:pubmed |
| pubmed-article:16391157 | pubmed:abstractText | The clinical value of revascularization and other procedures in patients with severe systolic heart failure is unclear. It has been suggested that assessing ischemia and viability by positron emission tomography (PET) with fluorodeoxyglucose (FDG) imaging may identify patients for whom revascularization may lead to improved survival. We performed a propensity analysis to determine whether there might be a survival advantage from revascularization. | lld:pubmed |
| pubmed-article:16391157 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16391157 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16391157 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16391157 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16391157 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16391157 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16391157 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16391157 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16391157 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16391157 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16391157 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:16391157 | pubmed:issn | 1524-4539 | lld:pubmed |
| pubmed-article:16391157 | pubmed:author | pubmed-author:BlackstoneEug... | lld:pubmed |
| pubmed-article:16391157 | pubmed:author | pubmed-author:McCarthyPatri... | lld:pubmed |
| pubmed-article:16391157 | pubmed:author | pubmed-author:LauerMichael... | lld:pubmed |
| pubmed-article:16391157 | pubmed:author | pubmed-author:PothierClaire... | lld:pubmed |
| pubmed-article:16391157 | pubmed:author | pubmed-author:Abdel-LatifAh... | lld:pubmed |
| pubmed-article:16391157 | pubmed:author | pubmed-author:TarakjiKhaldo... | lld:pubmed |
| pubmed-article:16391157 | pubmed:author | pubmed-author:BrunkenRichar... | lld:pubmed |
| pubmed-article:16391157 | pubmed:author | pubmed-author:Al-ChekakieM... | lld:pubmed |
| pubmed-article:16391157 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16391157 | pubmed:day | 17 | lld:pubmed |
| pubmed-article:16391157 | pubmed:volume | 113 | lld:pubmed |
| pubmed-article:16391157 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16391157 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16391157 | pubmed:pagination | 230-7 | lld:pubmed |
| pubmed-article:16391157 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:meshHeading | pubmed-meshheading:16391157... | lld:pubmed |
| pubmed-article:16391157 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16391157 | pubmed:articleTitle | Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. | lld:pubmed |
| pubmed-article:16391157 | pubmed:affiliation | Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. | lld:pubmed |
| pubmed-article:16391157 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16391157 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16391157 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16391157 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16391157 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16391157 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16391157 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16391157 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16391157 | lld:pubmed |
